South African coronavirus variant may ‘obviate’ antibody drugs, former FDA head says
January 07 2021, 08:00
Though COVID-19 vaccines will likely render effective against the South African coronavirus variant -- according to an infectious disease expert -- the former head of the Food and Drug Administration said the strain may “obviate” other countermeasures, including antibody drugs.
Though COVID-19 vaccines will likely render effective against the South African coronavirus variant -- according to an infectious disease expert -- the former head of the Food and Drug Administration said the strain may “obviate” other countermeasures, including antibody drugs.
Source:
FOX News